YIH
XERS icon

Y-Intercept (HK)’s Xeris Biopharma Holdings XERS Stock Holding History

Y-Intercept (HK)’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
411,346
+249,553
+154% +$1.59M 0.06% 449
2026
Q1 		$938K Buy
161,793
+71,148
+78% +$472K 0.02% 1064
2025
Q4 		$712K Buy
90,645
+8,464
+10% +$66.6K 0.02% 1117
2025
Q3 		$669K Sell
82,181
-254,033
-76% -$1.69M 0.02% 1155
2025
Q2 		$1.57M Buy
336,214
+291,696
+655% +$1.34M 0.04% 715
2025
Q1 		$244K Buy
+44,518
New +$180K 0.02% 975

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Y-Intercept (HK)'s XERS Position: Q2 2026 in Review

Y-Intercept (HK) increased its Xeris Biopharma Holdings (XERS) stake by 154% in Q2 2026, buying an estimated $1.59M and bringing the position to 411,346 shares worth $3.26M. The position accounts for 0.06% of the portfolio, ranked #449.

Y-Intercept (HK) first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Y-Intercept (HK) held 411,346 shares of Xeris Biopharma Holdings worth $3.26M as of Q2 2026.
  • Y-Intercept (HK) bought 249,553 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.59M.
  • Xeris Biopharma Holdings made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #449 holding.
  • Y-Intercept (HK) first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.